FCMI
Foresite Capital Management II Portfolio holdings
AUM
$29.2M
This Quarter Return
+8%
1 Year Return
+44.84%
3 Year Return
-66.21%
5 Year Return
-37.37%
10 Year Return
–
AUM
$372M
AUM Growth
+$372M
(-15%)
Cap. Flow
-$97.9M
Cap. Flow
% of AUM
-26.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
10x Genomics
TXG
|
$97.9M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $343M | 92.37% |
1,753,528
-500,000
| -22% | -$97.9M |
|
2
Novavax
NVAX
$1.21B
| $14.3M | 3.85% |
67,373
| – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $8.31M | 2.24% |
1,000,002
| – | – |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $5.76M | 1.55% |
45,884
| – | – |
|